DK3285767T3 - Behandling af smerte - Google Patents
Behandling af smerte Download PDFInfo
- Publication number
- DK3285767T3 DK3285767T3 DK16718885.3T DK16718885T DK3285767T3 DK 3285767 T3 DK3285767 T3 DK 3285767T3 DK 16718885 T DK16718885 T DK 16718885T DK 3285767 T3 DK3285767 T3 DK 3285767T3
- Authority
- DK
- Denmark
- Prior art keywords
- vol
- imidazo
- tetrahydro
- isopropyl
- pyridine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1507048.5A GB201507048D0 (en) | 2015-04-24 | 2015-04-24 | Treatment of pain |
| PCT/GB2016/051122 WO2016170353A1 (en) | 2015-04-24 | 2016-04-22 | Treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3285767T3 true DK3285767T3 (da) | 2019-04-29 |
Family
ID=53488643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16718885.3T DK3285767T3 (da) | 2015-04-24 | 2016-04-22 | Behandling af smerte |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20180104223A1 (da) |
| EP (1) | EP3285767B8 (da) |
| JP (2) | JP2018520984A (da) |
| KR (1) | KR20170139047A (da) |
| CN (1) | CN107530330A (da) |
| AU (1) | AU2016252237B2 (da) |
| BR (1) | BR112017019337A2 (da) |
| CA (1) | CA2979160A1 (da) |
| DK (1) | DK3285767T3 (da) |
| EA (1) | EA032512B1 (da) |
| ES (1) | ES2720035T3 (da) |
| GB (1) | GB201507048D0 (da) |
| HK (1) | HK1249865B (da) |
| HU (1) | HUE043871T2 (da) |
| IL (1) | IL254155B (da) |
| MX (1) | MX2017013047A (da) |
| PL (1) | PL3285767T3 (da) |
| PT (1) | PT3285767T (da) |
| SG (1) | SG11201707870SA (da) |
| TR (1) | TR201905392T4 (da) |
| WO (1) | WO2016170353A1 (da) |
| ZA (1) | ZA201705847B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201304526D0 (en) | 2013-03-13 | 2013-04-24 | Proximagen Ltd | New compounds |
| GB201507031D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | New pharmaceutical salt forms |
| GB201507036D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | Crystalline enzyme inhibitor compound |
| JP2019502672A (ja) * | 2015-12-07 | 2019-01-31 | ベネボレンタイ ケンブリッジ リミティド | 疼痛の治療のためのｖａｐ−１阻害剤 |
| GB201618029D0 (en) | 2016-10-25 | 2016-12-07 | Proximagen Ltd | New process |
| GB201709136D0 (en) * | 2017-06-08 | 2017-07-26 | Proximagen Ltd | New therapeutic uses of enzyme inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0639972A1 (en) * | 1992-05-15 | 1995-03-01 | University Of Saskatchewan | Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis |
| EP1791835A2 (en) * | 2004-09-09 | 2007-06-06 | Astellas Pharma Inc. | Thiazole derivatives having vap-1 inhibitory activity |
| US20070066646A1 (en) * | 2005-08-02 | 2007-03-22 | Genmedica Therapeutics Sl | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof |
| EP2029164B1 (en) | 2006-06-07 | 2015-12-23 | The Board of Trustees of the Leland Stanford Junior University | Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy |
| TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| EA019167B1 (ru) * | 2008-09-16 | 2014-01-30 | Проксимаген Лимитед | Соединения, ингибирующие активность семикарбазид-чувствительной аминооксидазы |
| FI20115234A0 (fi) * | 2011-03-08 | 2011-03-08 | Biotie Therapies Corp | Uusia pyridatsinoni- ja pyridoniyhdisteitä |
| AU2014279863A1 (en) * | 2013-06-12 | 2016-01-28 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
| EP3131539B1 (en) * | 2014-04-15 | 2018-12-05 | Pécsi Tudományegyetem | Semicarbazide-sensitive amine oxidase inhibitors for use as analgesics in traumatic neuropathy and neurogenic inflammation |
| GB201507031D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | New pharmaceutical salt forms |
| GB201507036D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | Crystalline enzyme inhibitor compound |
-
2015
- 2015-04-24 GB GBGB1507048.5A patent/GB201507048D0/en not_active Ceased
-
2016
- 2016-04-22 EP EP16718885.3A patent/EP3285767B8/en active Active
- 2016-04-22 CA CA2979160A patent/CA2979160A1/en active Pending
- 2016-04-22 AU AU2016252237A patent/AU2016252237B2/en not_active Ceased
- 2016-04-22 PL PL16718885T patent/PL3285767T3/pl unknown
- 2016-04-22 ES ES16718885T patent/ES2720035T3/es active Active
- 2016-04-22 TR TR2019/05392T patent/TR201905392T4/tr unknown
- 2016-04-22 KR KR1020177032024A patent/KR20170139047A/ko unknown
- 2016-04-22 JP JP2017555657A patent/JP2018520984A/ja active Pending
- 2016-04-22 SG SG11201707870SA patent/SG11201707870SA/en unknown
- 2016-04-22 BR BR112017019337-0A patent/BR112017019337A2/pt not_active Application Discontinuation
- 2016-04-22 WO PCT/GB2016/051122 patent/WO2016170353A1/en active Application Filing
- 2016-04-22 HU HUE16718885A patent/HUE043871T2/hu unknown
- 2016-04-22 DK DK16718885.3T patent/DK3285767T3/da active
- 2016-04-22 EA EA201792123A patent/EA032512B1/ru not_active IP Right Cessation
- 2016-04-22 PT PT16718885T patent/PT3285767T/pt unknown
- 2016-04-22 CN CN201680023299.XA patent/CN107530330A/zh active Pending
- 2016-04-22 MX MX2017013047A patent/MX2017013047A/es unknown
- 2016-04-22 US US15/567,555 patent/US20180104223A1/en not_active Abandoned
-
2017
- 2017-08-24 IL IL254155A patent/IL254155B/en active IP Right Grant
- 2017-08-28 ZA ZA2017/05847A patent/ZA201705847B/en unknown
-
2018
- 2018-07-19 HK HK18109397.0A patent/HK1249865B/zh not_active IP Right Cessation
-
2021
- 2021-01-28 JP JP2021012097A patent/JP2021073257A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| HK1249865B (zh) | 2019-12-06 |
| AU2016252237A1 (en) | 2017-10-05 |
| EA032512B1 (ru) | 2019-06-28 |
| US20180104223A1 (en) | 2018-04-19 |
| EA201792123A1 (ru) | 2018-03-30 |
| HUE043871T2 (hu) | 2019-09-30 |
| MX2017013047A (es) | 2017-12-08 |
| PT3285767T (pt) | 2019-05-20 |
| SG11201707870SA (en) | 2017-11-29 |
| IL254155A0 (en) | 2017-10-31 |
| JP2021073257A (ja) | 2021-05-13 |
| GB201507048D0 (en) | 2015-06-10 |
| CN107530330A (zh) | 2018-01-02 |
| JP2018520984A (ja) | 2018-08-02 |
| TR201905392T4 (tr) | 2019-05-21 |
| KR20170139047A (ko) | 2017-12-18 |
| WO2016170353A1 (en) | 2016-10-27 |
| EP3285767A1 (en) | 2018-02-28 |
| IL254155B (en) | 2021-02-28 |
| CA2979160A1 (en) | 2016-10-27 |
| AU2016252237B2 (en) | 2021-04-08 |
| ES2720035T3 (es) | 2019-07-17 |
| ZA201705847B (en) | 2020-03-25 |
| EP3285767B8 (en) | 2019-05-22 |
| EP3285767B1 (en) | 2019-03-20 |
| BR112017019337A2 (pt) | 2018-06-05 |
| PL3285767T3 (pl) | 2019-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3285767T3 (da) | Behandling af smerte | |
| DE69426376T2 (de) | Substituierte Azepino (2,1-a)isochinolin Verbindungen | |
| HUE031999T2 (en) | Cyclic n, n'-diarylthioureas and n, n'-diarylureas as androgen receptor antagonists, anticancer agents, methods for their preparation and their use | |
| US20210024518A1 (en) | Therapeutic compound and use in therapy | |
| EP3286190B1 (en) | Pharmaceutical salt forms of an inhibitor of semicarbazide-sensitive amine oxidase (ssao) | |
| EP3036006B1 (en) | Trichostatin a for multiple myeloma treatment | |
| EP3286189B1 (en) | Crystalline mesylate salt as semicarbazide-sensitive amine oxidase (ssao) enzyme inhibitor | |
| JP2019085364A (ja) | ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途 | |
| Angelova et al. | Anticonvulsant activity of newly synthesized 2H-chromene based hydrazones in ICR mice | |
| WO2013038200A2 (en) | Neurodevelopmental disorders | |
| KR102628246B1 (ko) | 선택성 a2a 수용체 대항제 | |
| EP0151687A1 (en) | Process for the isolation of 5-Allyl-2-(3,4-dimethoxyphenyl)-3a-methoxy-3-methyl-2,3,3a,6-tetrahydro-6-oxobenzofuran and pharmaceutical composition for treating inflammatory conditions | |
| EP4177253A1 (en) | Tetrahydroisoquinoline derivative, preparation method therefor, and medical use thereof | |
| WO2006025251A1 (ja) | 生理活性物質ビセライドａ、ビセライドｂ及びビセライドｃ、それらの製造法並びにそれらの用途 | |
| JPH08504418A (ja) | 中枢神経疾病治療用のトリアゾロキナゾリン |